Pneumonia

Pneumonia is an acute inflammatory condition of the lung parenchyma, primarily affecting the microscopic air sacs known as alveoli (StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK526116/). It is typically caused by infectious agents such as bacteria, viruses, or fungi, which lead to the accumulation of fluid or pus in the lungs, impairing gas exchange (WHO, https://www.who.int/news-room/fact-sheets/detail/pneumonia). As a disease state rather than a discrete molecular target, it serves as the clinical context for the application of various antimicrobial and anti-inflammatory therapies. Drug development in this space focuses on specific molecular targets within pathogens, such as bacterial cell wall synthesis or viral replication enzymes, or host-response pathways like cytokine signaling (Mayo Clinic, https://www.mayoclinic.org/diseases-conditions/pneumonia/symptoms-causes/syc-20354204). Consequently, pneumonia itself does not possess molecular classifications or inherent biological functions like a protein receptor or enzyme. The condition remains a major cause of morbidity and mortality globally, necessitating ongoing research into both pathogen-specific and host-directed treatments.

Other names

PneumonitisLung infectionCommunity-acquired pneumoniaHospital-acquired pneumoniaVentilator-associated pneumonia

Not applicable as Pneumonia is a disease entity/indication, not a molecular target. Therapeutic interventions target specific bacterial, viral, or fungal proteins or host inflammatory mediators.